AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (May 4, 2006). doi:10.1152/ajpgi.00147.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/4/G605    most recent
00147.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, W.
Right arrow Articles by Murthy, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, W.
Right arrow Articles by Murthy, K. S.
Submitted on March 30, 2006
Accepted on May 1, 2006

Characterization of S1P1 and S1P2 Receptor Function in Smooth Muscle by Receptor Silencing and Receptor Protection

Wenhui Hu1*, Sunila Mahavadi1, Jiean Huang2, Fang Li2, and Karnam S. Murthy1

1 Physiology, Virginia Commonwealth University, Richmond, Virginia, United States
2 Medicine, Virginia Commonwealth University, Richmond, Virginia, United States

* To whom correspondence should be addressed. E-mail: whu{at}vcu.edu.

Sphingosine-1-phosphate (S1P) induces an initial Ca2+-dependent contraction followed by a sustained Ca2+-independent, RhoA-mediated contraction in rabbit gastric smooth muscle cells. The cells co-express S1P1 and S1P2 receptors, but the signaling pathways initiated by each receptor type and the involvement of one or both receptors in contraction are not known. Lentiviral vectors encoding small interfering RNAs (siRNAs) were transiently transfected into cultured smooth muscle cells to silence S1P1 or S1P2 receptors. Phospholipase C (PLC)-{beta} activity and Rho kinase activity were used as markers of pathways mediating initial and sustained contraction, respectively. Silencing of S1P1 receptors abolished S1P-stimulated activation of G{alpha}i3 and partially inhibited activation of G{alpha}i1, whereas silencing of S1P2 receptors abolished activation of G{alpha}q, G{alpha}13, and G{alpha}i2, and partially inhibited activation of G{alpha}i1. Silencing of S1P2 but not S1P1 receptors suppressed S1P-stitmulated PLC-{beta} and Rho kinase activities, implying that both signaling pathways were mediated by S1P2 receptors. The results obtained by receptor silencing were corroborated by receptor inactivation. The selective S1P1 receptor agonist, SEW2871 did not stimulate PLC-{beta} or Rho kinase activity or induce initial and sustained contraction; when this agonist was used to protect S1P1 receptors so as to enable chemical inactivation of S1P2 receptors, S1P did not elicit contraction, confirming that initial and sustained contraction was mediated by S1P2 receptors. Thus, S1P1 and S1P2 receptors are coupled to distinct complements of G proteins. Only S1P2 receptors activate PLC-{beta} and Rho kinase and mediate initial and sustained contraction.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.